This is a study were where subjects were randomized to use 3 different concentration concentrations of nicotine e-nicotine liquid. The subject were confined to a clinical after using , or their usual brand of cigarettes. The subjects used the product at home for 2 weeks. This 2-week period allowed subjects to become familiar with the e-cigarette. After two 2 weeks, the subjects were confined to the clinical clinic for one 1 day. They were required to not use any e-cigarettes any tobacco products for 12 hours prior to the visit. Subjects had to have CO level levels below a pre-specified prespecified level , to attend the visit. IF If the level , was too high, the visit ws re-scheduledwas rescheduled. Subjects were were instructed to take 10 puffs on the e-cigarette/usual brand of cigarettes in the morning and afternoon. Puff topography was measured in the morning and afternoon using the same device for all subjects. Subjects were not allowed to use any tobacco products between the morning and afternoon sessions.
Device Identifiers (DI), a Study Reference domain, was used to identify the device used to measure puff topography. This provides a consistent variable (SPDEVID) for linking data. Because device identifiers exist independently from subjects, the DI domain does not contain USUBJID. Only 1 device was used for all subjects in the study.
Dataset wrap |
---|
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | SPDEVID | DISEQ | DIPARMCD | DIPARM | DIVAL | 1 | TOPT001 | DI | PUFANYXYZ | 1 | DEVTYPE | Device Type | PUFF TOPOGRAPHY ANALYZER | 2 | TOPT001 | DI | PUFANYXYZ | 2 | MODEL | Model | PUFFALYZER 900 | 3 | TOPT001 | DI | PUFANYXYZ | 3 | MANUF | Manufacturer | ACME |
|
|
The applicant submitted the Exposure (EX) domain to represent use of the tobacco product. Usage for the 2-week period is represented for each subject, along with the specified use during the in-clinic visit. The applicant elected not to represent each puff in this EX dataset, although each puff could have been recorded.
Dataset wrap |
---|
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | SPTOBID | EXSEQ | EXLNKID | EXTRT | EXDOSE | EXDOSTXT | EXDOSU | EXDOSFRM | EXROUTE | EXPSTRG | EXPSTRGU | EXSTDTC | EXENDTC |
---|
1 | TOPT001 | EX | 3001 | EC-333 | 1 |
| Nicotine e-liquid |
| AD LIBITUM |
| CARTRIDGE | RESPIRATORY (INHALATION) | 8 | mg/mL | 2020-06-26 | 2020-07-14 | 2 | TOPT001 | EX | 3001 | EC-333 | 2 | 1 | Nicotine e-liquid | 10 |
| PUFF | CARTRIDGE | RESPIRATORY (INHALATION) | 8 | mg/mL | 2020-07-15T9:00 | 2020-07-15TT9:45 | 3 | TOPT001 | EX | 3001 | EC-333 | 3 | 2 | Nicotine e-liquid | 10 |
| PUFF | CARTRIDGE | RESPIRATORY (INHALATION) | 8 | mg/mL | 2020-07-15T3:00 | 2020-07-15TT3:45 | 4 | TOPT001 | EX | 4001 | EC-333 | 1 |
| Nicotine e-liquid |
| AD LIBITUM |
| CARTRIDGE | RESPIRATORY (INHALATION) | 16 | mg/mL | 2020-09-06 | 2020-09-22 | 5 | TOPT001 | EX | 4001 | EC-333 | 2 | 1 | Nicotine e-liquid | 10 |
| PUFF | CARTRIDGE | RESPIRATORY (INHALATION) | 16 | mg/mL | 2020-09-22T9:00 | 2020-09-22T9:30 | 6 | TOPT001 | EX | 4001 | EC-333 | 3 | 2 | Nicotine e-liquid | 10 |
| PUFF | CARTRIDGE | RESPIRATORY (INHALATION) | 16 | mg/mL | 2020-09-22T3:00 | 2020-09-22T3:30 | 7 | TOPT001 | EX | 5004 |
| 1 |
| Cigarettes Brand XYZ |
| AD LIBITUM |
| CIGARETTE | RESPIRATORY (INHALATION) | 12.1 | mg/cigarette | 2020-10-08 | 2020-10-22 | 8 | TOPT001 | EX | 5004 |
| 2 | 1 | Cigarettes Brand XYZ | 10 |
| PUFF | CIGARETTE | RESPIRATORY (INHALATION) | 12.1 | mg/cigarette | 2020-10-22T9:00 | 2020-09-22T9:30 | 9 | TOPT0011 | EX | 5004 |
| 3 | 2 | Cigarettes Brand XYZ | 10 |
| PUFF | CIGARETTE | RESPIRATORY (INHALATION) | 12.1 | mg/cigarette | 2020-10-22T3:00 | 2020-09-22T3:30 |
|
|
The FAEX domain was used to represent the puff topography associated with the in-clinic visit. The Findings About Events or Interventions structure ("FA structure") is used to represent collected data that are findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. Not all findings associated with an event or intervention should be represented in the FA structure.
A puff-by puff analysis was performed. Only selected data for puffs 1 and 10 are shown. No data are shown for 2-9 to simplify dataset review. FATPT was used to represent the time point (in this case, AM and PM). Typically, applicants derive summary results using individual source data records; these summary results are represented in ADaM. However, if summary results are collected on a CRF or provided by an external vendor, these derived results can be represented in FAEX using the variable FACOLSRT. In this example, the applicant created an ADaM dataset to represent the summary data (not shown).
Dataset wrap |
---|
|
Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | TOBA-288 |
---|
|
Rowcaps |
---|
Rows 1, 6: | Show the number of puffs taken in the time interval specified in FADTC and FAENDTC. This was prespecified in the design, but the applicant reported the actual number of puffs taken. | Rows 2-5: | Show the various measurements recorded for subject 3001 for puff 1 during the morning administration of the tobacco product. FADTC and FAENDTC provide the timing of each puff. The individual puff data for the afternoon are not shown. | Rows 7-10: | Show the various measurements recorded for subject 3001 for puff 10 during the afternoon administration of the tobacco product. FADTC and FAENDTC provide the timing of each puff. The individual puff data for the morning session are not shown. Note: Data for puffs 2-9 are not shown to simplify dataset review. | Rows 12-15: | Show the various measurements recorded for subject 4001. Only a few rows are shown to simplify dataset review. |
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | SPDEVID | SPTOBID | FASEQ | FALNKID | FASPID | FATESTCD | FATEST | FAOBJ | FACAT | FAORRES | FAORRESU | FASTRESC | FASTRESU | VISITNUM | FADTC | FAENDTC | FATPT |
---|
1 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 1 | 1 |
| PUFF TOT | Total Number of Puffs | Nicotine e-liquid | PUFF TOPOGRAPHY | 10 | PUFFS | 10 | PUFFS | 2 | 2020-07-15T09:00 | 2020-07-15TT9:45 | AM | 2 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 2 | 1 | PUFF 1 | PUFFVOL | Puff Volume | Nicotine e-liquid | PUFF TOPOGRAPHY | 36.7 | mL/sec | 37 | mL/sec | 2 | 2020-07-15T09:01.36 | 2020-07-15T09:01.38 | AM | 3 | | FA | 3001 | PUFANYXYZ | EC-333 | 3 | 1 | PUFF 1 | AVGFLOW | Average Flow rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 15.5 | mL/sec | 15.5 | mL/sec | 2 | 2020-07-15T09:01.36 | 2020-07-15T09:01.38 | AM | 4 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 4 | 1 | PUFF 1 | PKFLOW | Peak Flow Rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 20.5 | mL/sec | 20.5 | mL/sec | 2 | 2020-07-15T09:01.36 | 2020-07-15T09:01.38 | AM | 5 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 5 | 1 | PUFF 1 | PUFFDUR | Puff Duration | Nicotine e-liquid | PUFF TOPOGRAPHY | 2.0 | msec | 1.6 | msec | 2 | 2020-07-15T09:01.36 | 2020-07-15T09:01.38 | AM | 6 | | FA | 3001 | PUFANYXYZ | EC-333 | 6 | 2 |
| PUFF TOT | Total Number of Puffs | e-nicotin liquid | PUFF TOPOGRAPHY | 9 | PUFFS | 9 | PUFFS | 2 | 2020-07-15T03:00 | 2020-07-15T03:30 | PM | 7 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 7 | 2 | PUFF 10 | INTPUFIN | Puff Interval | Nicotine e-liquid | PUFF TOPOGRAPHY | 910396.8 | sec | 910396.8 | sec | 2 | 2020-07-15T03:30:34 | 2020-07-15T03:30:36 | PM | 8 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 8 | 2 | PUFF 10 | PUFFVOL | Puff Volume | Nicotine e-liquid | PUFF TOPOGRAPHY | 43 | mL/sec | 43 | mL/sec | 2 | 2020-07-15T03:30:34 | 2020-07-15T03:30:36 | PM | 9 | | FA | 3001 | PUFANYXYZ | EC-333 | 9 | 2 | PUFF 10 | AVGFLOW | Average Flow rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 14.5 | mL/sec | 14.5 | mL/sec | 2 | 2020-07-15T03:30:34 | 2020-07-15T03:30:36 | PM | 10 | TOPT001 | FA | 3001 | PUFANYXYZ | EC-333 | 10 | 2 | PUFF 10 | PKFLOW | Peak Flow Rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 22.5 | mL/sec | 22.5 | mL/sec | 2 | 2020-07-15T03:30:34 | 2020-07-15T03:30:36 | PM | 12 | TOPT001 | FA | 4001 | PUFANYXYZ | EC-333 | 1 | 1 |
| PUFF TOT | Total Number of Puffs | Nicotine e-liquid | PUFF TOPOGRAPHY | 10 | PUFFS | 10 | PUFFS | 2 | 2020-08-15T9:00 | 2020-08-15TT9:45 | AM | 13 | | FA | 4001 | PUFANYXYZ | EC-333 | 2 | 1 | PUFF 1 | PUFFVOL | Puff Volume | Nicotine e-liquid | PUFF TOPOGRAPHY | 34.7 | mL/sec | 34 | mL/sec | 2 | 2020-08-15T09:01.36 | 2020-08-15T09:01.38 | AM | 14 | TOPT001 | FA | 4001 | PUFANYXYZ | EC-333 | 3 | 1 | PUFF 1 | AVGFLOW | Average Flow rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 15.5 | mL/sec | 15.5 | mL/sec | 2 | 2020-08-15T09:01.36 | 2020-08-15T09:01.38 | AM | 15 | TOPT001 | FA | 4001 | PUFANYXYZ | EC-333 | 4 | 1 | PUFF 1 | PKFLOW | Peak Flow Rate | Nicotine e-liquid | PUFF TOPOGRAPHY | 23.5 | mL/sec | 23.5 | mL/sec | 2 | 2020-08-15T09:01.36 | 2020-08-15T09:01.38 | AM |
|
|
The RELREC dataset was used to record the relationship between the records in EX and the records in FAEX.
Dataset wrap |
---|
|
Dataset2 |
---|
Row | STUDYID | RDOMAIN | USUBJID | IDVAR | IDVARVAL | RELTYPE | RELID |
---|
1 | TD23 | EX |
| EXLNKID |
| ONE | EXFA1 | 2 | TD23 | FAEX |
| FALNKID |
| MANY | EXFA1 | |
|